Decision to Enter into a 2 Billion Won Treasury Stock Acquisition Trust Contract (Shareholder Value Enhancement)
- Decision to enter into a 2 billion won treasury stock acquisition trust contract, contract period 2026.05.21~2026.11.20, purpose: shareholder value enhancement
- Expected shares to acquire: 715,563 common shares at an expected price of 2,795 won (based on prior day's closing price before board resolution)
- Treasury shares held before contract: 632,137 shares (2.05%), expected post-acquisition holding ratio approximately 4.36%
- Contract institution: Shinhan Investment Corp., Board resolution date: 2026.05.20, 2 outside directors attended, 1 absent
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Major Report (Decision on Entering into a Trust Contract for Acquisition of Treasury Shares)
- Company: REMED (302550)
- Submission: REMED CO.,LTD.
- Receipt: 05-20-2026